randomization

(redirected from randomisation)
Also found in: Dictionary, Thesaurus, Medical, Financial, Wikipedia.

randomization

[‚ran·də·mə′zā·shən]
(statistics)
Assigning subjects to treatment groups by use of tables of random numbers.
References in periodicals archive ?
Using Mendelian randomisation we found that higher BMI and fat mass are associated with an increased risk of aortic valve stenosis and most other cardiovascular diseases, suggesting that excess body fat is a cause of cardiovascular disease," Larsson explained.
Because of that randomisation, scientists could cross-check the numbers of people with or without a snippet related to a health risk or behaviour, such as, say, a strong likelihood to exercise, against another health outcome, such as severe depression.
After taking account of potentially influential factors, Mendelian randomisation analyses suggested that every additional year of education was associated with more myopia (a refractive error of 0.27 dioptres a year).
The randomisation was done only for the 2 study groups and not for the control group that served as a comparator group.
Its offerings will be included into the ClinPhone RTSM suite, the aim being to deliver more efficient patient randomisation and clinical supply solutions, the buyer said.
Randomisation, well appropriated for drugs assessment, can be a controversial issue for complex interventions assessment.
NORDIC BUSINESS REPORT-11 December 2009-Norwegian Algeta says patients' randomisation started in US trial with Alpharadin(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com
The assessment was made by three investigators (LS, HKFvS, AC) and included randomisation, blinding, patient selection, population description, reproducibility and definitions of carriage and infection.
ClinPhone said the service enables fast and cost-effective development of Interactive Voice Response (IVR) and Interactive Web Response (IWR) solutions for randomisation and trial supply management.
Male circumcision was offered to the intervention group immediately after randomisation and to the control group at the end of follow-up.
M2 PHARMA-August 17, 2015-Neurocrine Biosciences completes subject randomisation of phase III clinical trial of NBI-98854